ARE BIOSIMILARS EQUIVALENT TO ORIGINATOR MOLECULES IN THE REAL-WORLD? ASSESSMENTS OF EFFICACY, TOXICITY, AND TOLERABILITY OF INFLIXIMABS IN INFLIXIMAB-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Edgerton, C. [1 ]
Adams, C. [1 ]
Frick, A. [2 ]
Helfgott, S. M. [3 ]
Huston, K. [4 ]
Milligan, S. [5 ]
Singh, J. A. [6 ]
Soloman, N. [7 ]
机构：
[1] Articularis Healthcare, Summerville, SC USA
[2] Trio Hlth Analyt, La Mirada, CA USA
[3] Brigham & Womens Hosp, Boston, MA USA
[4] Ctr Rheumat Dis Allergy Immunol, Kansas City, MO USA
[5] Trio Hlth Analyt, Louisville, CO USA
[6] Univ Alabama Birmingham, Birmingham, AL USA
[7] Arizona Arthrit, Phoenix, AZ USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO154
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Real-world switching and discontinuation outcomes of infliximab biosimilars in patients with rheumatoid arthritis: A scoping review
    Yin, Yue
    McDermott, Cara
    Lockhart, Catherine
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (09): : 985 - 998
  • [2] OUTCOMES WITH INFLIXIMAB AND ITS BIOSIMILARS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA): REAL-WORLD EXPERIENCE IN THE US
    Helfgott, S. M.
    Radtchenko, J.
    Soloman, N.
    Huston, K.
    Singh, J. A.
    Edgerton, C.
    VALUE IN HEALTH, 2021, 24 : S14 - S15
  • [3] Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naive to or switched from biologics
    Takeuchi, Tsutomu
    Nishikawa, Kiyohiro
    Yamada, Fumika
    Ohshima, Shiro
    Inoue, Makoto
    Yoshioka, Yutaka
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2022, 32 (04) : 718 - 727
  • [4] Real-World Utilization of Infliximab (IFX) and Its Biosimilars in Patients (Pts) with Rheumatoid Arthritis (RA) Since the First Biosimilar Approval in the US
    Helfgott, Simon
    Radtchenko, Janna
    Soloman, Nehad
    Huston, Kent Kwas
    Singh, Jasvinder
    Edgerton, Colin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden
    Lekander, Ingrid
    Borgstrom, Fredrik
    Svarvar, Patrick
    Ljung, Tryggve
    Carli, Cheryl
    van Vollenhoven, Ronald F.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (01) : 54 - 61
  • [6] Biosimilar Infliximab Therapy in Rheumatoid Arthritis, Axial Spondyloarthritis and Psoriatic Arthritis: A Long-term Follow-up Study on Infliximab-naive Patients and Switched Patients from the Originator to the Biosimilar CT-P13
    Marotte, Hubert
    Assing, Maryse
    Mammar, Nadir
    Brault, Yves
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1683 - 1685
  • [7] Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis
    Peeyush Kumar
    Sudheer K. Vuyyuru
    Bhaskar Kante
    Saurabh Kedia
    Pabitra Sahu
    Mukesh Kumar Ranjan
    Sandeep Mundhra
    Rithvik Golla
    Mukesh Kumar
    Shubi Virmani
    Anvita Gupta
    Nidhi Yadav
    Govind Makharia
    Vineet Ahuja
    Indian Journal of Gastroenterology, 2022, 41 : 446 - 455
  • [8] Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis
    Kumar, Peeyush
    Vuyyuru, Sudheer K.
    Kante, Bhaskar
    Kedia, Saurabh
    Sahu, Pabitra
    Ranjan, Mukesh Kumar
    Mundhra, Sandeep
    Golla, Rithvik
    Kumar, Mukesh
    Virmani, Shubi
    Gupta, Anvita
    Yadav, Nidhi
    Makharia, Govind
    Ahuja, Vineet
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (05) : 446 - 455
  • [9] Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis
    Al Tabaa, Omar
    Hecquet, Sophie
    Thomas, Marion
    Carves, Sandrine
    Combier, Alice
    Miceli-Richard, Corinne
    Molto, Anna
    Fogel, Olivier
    Allanore, Yannick
    Avouac, Jerome
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
  • [10] CORTICOSTEROID USE IN RHEUMATOID ARTHRITIS PATIENTS ON INFLIXIMAB: TREATMENT IMPLICATIONS BASED ON A REAL-WORLD CANADIAN POPULATION
    Haraoui, B.
    Jovaisas, A.
    Bensen, W. G.
    Faraawi, R.
    Kelsall, J.
    Dixit, S.
    Rampakakis, E.
    Sampalis, J. S.
    Nantel, F.
    Otawa, S.
    Lehman, A. J.
    Shawi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 224 - 224
12345